The FDA gave Hope Bioscience's stem cell therapy RMAT designation after clinical data suggested it may improve life for ...

Most MS neurologists in the US have received physician pharma payments, and a study suggests this may influence their ...

DMT vs. Symptom Management DMTs are drugs to improve the long-term outlook of the condition. They reduce the number and severity of MS relapses and slow down the natural progression of the disease.

Multiple Sclerosis: Causes, Signs and Treatments originally appeared on usnews.com Update 03/10/25: This story was previously published at an earlier date and has been updated with new information.

Nearly 80% of neurologists prescribing multiple sclerosis drugs received $164M from pharma companies, and a new BMJ Open ...

Research highlights a strong link between Epstein-Barr virus and multiple sclerosis (MS), suggesting new therapeutic ...

Experts see tolebrutinib as part of a broader shift toward treatments that target the neurodegeneration in MS, not just its inflammatory flare-ups.

Considering the CLARITY Phase III study results, cladribine tablets may offer several improvements over existing MS drugs including a simple, short-course annual dosing regimen of either 2 or 4 ...

The first real guidelines on the use of disease-modifying therapies cover the treatment of adults with MS or CIS, the monitoring of treatment response, the stopping and switching of treatment ...

A recent study reveals that over one-third of individuals with relapsing-remitting multiple sclerosis (MS) do not fully ...